Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of oral nolasiban to improve pregnancy outcomes after fresh single blastocyst transfer in IVF
2018-002910-11Phase 3Completed
- Sponsor
- ObsEva SA
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in implantation failure comparing Nolasiban with Placebo (2 arms). Primary endpoint: Ongoing pregnancy rate. Started Sep 2018; status: completed.
02
Drugs
nolasiban
03
Conditions
implantation failure
Beyond the preview
Go deeper on 2018-002910-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002910-11.